Machine Learning

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

With many GenAI projects failing to deliver returns, Portal26's new platform aims to turn AI investment chaos into a coherent, profitable strategy.

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

India's top university is planting its flag in the US, launching a new foundation to accelerate deep-tech startups and forge a transatlantic tech pipeline.

The biotech firm launches clinical-grade solutions at ATW 2026, promising to boost cell therapy quality, consistency, and regulatory alignment.

Fluent sells its Winopoly subsidiary to focus on its booming Commerce Media business, a strategic pivot aiming for long-term value amid a shifting AdTech landscape.

With investors watching, Lincoln Electric's CEO and CFO will detail their vision for automation, global growth, and financial performance at a key conference.

Hoymiles launches its HiOne all-in-one battery, packing industry-leading efficiency, 0ms backup, and AI-driven savings into a sleek, minimalist design.

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

ASUS's new PE1000U packs Intel Core Ultra 2 power into a tiny, fanless chassis, aiming to accelerate AI at the rugged industrial edge.

A new partnership, featured on the Nasdaq Tower, combines AI e-commerce with specialized payment solutions to tackle the complexities of cross-border trade.

A new cancer drug using DNA fragments to deliver chemotherapy more safely has been cleared for US trials, offering hope for less toxic treatments.

A new report predicts autonomous AI agents will soon run marketing, transforming brand-consumer relationships and the very role of the CMO. Are you ready?

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Ascentage Pharma's next-gen BTK degrader, APG-3288, receives dual IND clearance, paving the way for clinical trials to fight resistant blood cancers.